Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 29, 2008
Grant Date -
N/A
app pub date -
Jun 4, 2002
filing date -
Jul 20, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to endothelial and smooth muscle cells genetically altered to express or over-express one or more cell adhesion factors. The invention further relates to cells genetically altered to express or over-express both cell proliferation growth factor(s) and cell adhesion factor(s). In addition, the present invention relates to nucleic acid constructs and nucleic acid construct systems that encode the cell adhesion and cell proliferation growth factors and that are used to transfect/transform the cells so that they can express the factors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully